May 2015

Safety Related Changes

Cimzia (certolizumab pegol) has been shown to reduce the rate of progression of joint damage as measured by X-ray, when given in combination with MTX.

Dorzolamide/ Timolol Sandoz 20/5 (dorzolamide (as hydrochloride) and timolol (as maleate)) is now contraindicated in severe renal impairment (CrCl < 30 ml/min) or hyperchloremic acidosis.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au